Park Medi World Ltd. IPO Review: Dates, Price, GMP, Financials & Peer Comparison

Park Medi World Ltd. is a leading private hospital chain in North India, specializing in multi-super speciality healthcare services. Established with a vision to deliver high-quality medical care, the company operates a network of hospitals equipped with advanced technology and a team of experienced medical professionals.

Park Medi World Ltd. has built a strong reputation for its patient-centric approach, state-of-the-art infrastructure, and commitment to clinical excellence. With a presence across key cities in North India, the company continues to expand its footprint and enhance its healthcare offerings to serve a growing patient base. The upcoming IPO marks a significant milestone in Park Medi World Ltd.’s journey, aiming to strengthen its financial position and support further expansion in the Indian healthcare sector.

Park Medi World Ltd. IPO Details

Park Medi World Ltd. is launching a book-built IPO with a total issue size of ₹920 crore, consisting of a fresh issue of ₹770 crore and an offer for sale (OFS) of ₹150 crore. The IPO will be open from December 10 to December 12, 2025, with shares offered in the price band of ₹154–₹162. The face value per share is ₹2, and the minimum lot size is 92 shares, making the minimum investment ₹14,904. The shares will be listed on both BSE and NSE on December 17, 2025.

IPO Review and Investment Outlook

Park Medi World Ltd. IPO stands out with its solid hospital network, healthy financials, and strong promoter backing. The IPO’s primary objective is debt reduction and hospital expansion, which bodes well for future growth. The grey market premium and anchor investor participation further reinforce positive sentiment. However, investors should monitor regulatory and operational risks, especially in the healthcare sector. Overall, the IPO offers a balanced risk-reward profile for long-term investors.

IPO Key Details Table

Market Lot Size and Category-wise Reservation

The IPO has a uniform lot size of 92 shares for all investor categories. Retail investors can apply for a maximum of 1,196 shares (₹193,752). The reservation structure is as follows:

Grey Market Premium (GMP)

The Park Medi World Ltd. IPO is witnessing strong demand in the grey market, with the GMP trading at ₹18–₹22 per share. This indicates a positive sentiment among investors and suggests a listing gain potential of 12–14% if the IPO is listed at the upper end of the price band.​

Anchor Investors

The IPO has secured anchor investors such as Abakkus Asset Manager, Carnelian, SBI General Insurance, Sattva Developers, and Urudavan Investment. These investors collectively acquired a 3.6% stake between October and November 2025, reflecting confidence in the company’s growth prospects.​

Merchant Bankers

The IPO is managed by leading merchant bankers, including Nuvama Wealth Management, CLSA India, DAM Capital Advisors, and Intensive Fiscal Services. Kfin Technologies is the registrar to the issue.​

Park Medi World Ltd. Allotment Details

Allotment of shares will be finalized by December 16, 2025. Refunds and credit of shares to demat accounts will be processed by December 17, 2025, with the shares listed on December 17, 2025.​

Allotment check link: Park Medi World Ltd.

Promoters Holding Pattern

The promoters currently hold 95.55% of the company’s equity. Post-IPO, their holding will reduce to 82.89%. Institutional investors collectively hold 4.55%.

Company Financial Statements

Park Medi World Ltd. reported robust financials for FY25:

Valuation Report

At the upper end of the price band (₹162), the IPO is valued at a P/E of 25.14x based on FY25 EPS of ₹6.44. The price-to-book value is 6.09x.

Park Medi World Ltd. Company Details

• Company Name: Park Medi World Ltd.

• Corporate Identity Number (CIN): U85110DL2011PLC212901

• Registered Office Address:
  12, Meera Enclave, Near Keshopur, Bus Depot, Outer Ring Road, New Delhi – 110018, Delhi, India​

• Corporate Office Address:
  Park Tower, Plot No. 521, Udyog Vihar Phase 3, Gurugram – 122022, Haryana, India​

• Company Secretary & Compliance Officer:
  Abhishek Kapoor
  Phone: +91 124 696 0000
  Email: company.secretary@parkhospital.in​

• Website: www.parkhospital.in

• Promoters: Dr. Ajit Gupta and Dr. Ankit Gupta​

Registrar to the Issue (Kfin Technologies Ltd.)

• Registrar Name: Kfin Technologies Ltd.

• Registrar Address:
  Financial District, Nanakramguda, Serilingampally, Hyderabad – 500032, Telangana, India​

• Registrar Contact:
  Phone: 040 6716 2222, 040 7961 1000​

• Registrar Email: parkmedi.ipo@kfintech.com​

• Registrar Website: www.kfintech.com

Corona Remedies IPO Details

Nadim

Mr. Nadim Abbas M G is an Intermediate Chartered Accountant with a strong background in Information Technology. He combines his expertise in IT with a deep understanding of the stock market, making him a valuable resource for both financial and technical insights. With hands-on experience in accounting, IT systems, and stock market analysis, Nadim excels in bridging the gap between finance and technology, offering strategic advice and expert guidance in both domains.